In an era where medicine is increasingly personalized, clinical trials often suffer from small samples. As a consequence, treatment comparison based on the data of these trials may result in inconclusive decisions. Efficient decision-making strategies are highly needed so decisions can be made with smaller samples without increasing the risk of errors. The current chapter centers around one such strategy: Including information from multiple outcomes in the decision, thereby focusing on data from binary outcomes. Key elements of the approach are (1) criteria for treatment comparison that are suitable for two outcomes, and (2) a multivariate Bayesian technique to analyze multiple binary outcomes simultaneously. The conceptual discussion of th...
Design and analysis of clinical trials imply decisions that often involve multiple parties. We focus...
Many formal statistical procedures for phase I dose-finding studies have been proposed. Most concern...
The primary scientific goal of a randomized clinical trial of two treatments, A and B, is to compare...
Clinical trials often evaluate multiple outcome variables to form a comprehensive picture of the eff...
University of Minnesota Ph.D. dissertation. August 2013. Major: Biostatistics. Advisors: Bradley P. ...
In this paper, a Bayesian approach is developed for simultaneously comparing multiple experimental t...
International audienceThe aim of phase II single-arm clinical trials of a new drug is to determine w...
The aim of phase II single-arm clinical trials of a new drug is to determine whether it has sufficie...
Background Adaptive designs offer added flexibility in the execution of clinical tri...
Current practice for sample size computations in clinical trials is largely based on frequentist or ...
This paper presents a simple Bayesian approach to sample size determination in clinical trials. It i...
It is increasingly common in clinical trials to design studies for which more than one primary outco...
It is common for a number of potentially effective treatments to be available for clinical evaluatio...
Background: In clinical setting, to answer a research question, very often more than one outcome var...
Bayesian analysis of a non-inferiority trial is advantageous in allowing direct probability statemen...
Design and analysis of clinical trials imply decisions that often involve multiple parties. We focus...
Many formal statistical procedures for phase I dose-finding studies have been proposed. Most concern...
The primary scientific goal of a randomized clinical trial of two treatments, A and B, is to compare...
Clinical trials often evaluate multiple outcome variables to form a comprehensive picture of the eff...
University of Minnesota Ph.D. dissertation. August 2013. Major: Biostatistics. Advisors: Bradley P. ...
In this paper, a Bayesian approach is developed for simultaneously comparing multiple experimental t...
International audienceThe aim of phase II single-arm clinical trials of a new drug is to determine w...
The aim of phase II single-arm clinical trials of a new drug is to determine whether it has sufficie...
Background Adaptive designs offer added flexibility in the execution of clinical tri...
Current practice for sample size computations in clinical trials is largely based on frequentist or ...
This paper presents a simple Bayesian approach to sample size determination in clinical trials. It i...
It is increasingly common in clinical trials to design studies for which more than one primary outco...
It is common for a number of potentially effective treatments to be available for clinical evaluatio...
Background: In clinical setting, to answer a research question, very often more than one outcome var...
Bayesian analysis of a non-inferiority trial is advantageous in allowing direct probability statemen...
Design and analysis of clinical trials imply decisions that often involve multiple parties. We focus...
Many formal statistical procedures for phase I dose-finding studies have been proposed. Most concern...
The primary scientific goal of a randomized clinical trial of two treatments, A and B, is to compare...